[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-366896-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-366896-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","targeting-human-cancer-cells-with-cannabidiol-cbd-apoptotic-cytotoxicity-in-hela-mda-mb-231-and-caco-2-lines","Targeting Human Cancer Cells with Cannabidiol (CBD) - Apoptotic Cytotoxicity in HeLa, MDA-MB-231, and CaCo-2 Lines","","Cannabidiol (CBD), a non-psychoactive phytocannabinoid from Cannabis sativa, is investigated for anticancer relevance by comparing its effects on human cancer cell lines and selected non-cancerous controls. HeLa, MDA-MB-231, and CaCo-2 were exposed to CBD at 5, 10, and 20 µM across 24–96 h, alongside HaCaT and HUVEC controls. Cytotoxicity was quantified using MTT assays, nuclear morphology was examined by DAPI staining, and cell death pathways were characterized via flow cytometry with apoptosis/necrosis markers. LC50 values and morphological stress and death features were reported to highlight CBD’s adjunctive therapeutic potential versus non-malignant cells.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/targeting-human-cancer-cells-with-cannabidiol-cbd-apoptotic-cytotoxicity-in-hela-mda-mb-231-and-caco-2-lines/366896/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/targeting-human-cancer-cells-with-cannabidiol-cbd-apoptotic-cytotoxicity-in-hela-mda-mb-231-and-caco-2-lines/366896.png","ImageObject",300,407,{"name":42,"@type":43},"mieayamfan","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Which cell lines were used to evaluate CBD’s cytotoxicity?","Question",{"text":63,"@type":64},"HeLa, MDA-MB-231, and CaCo-2 were used as human cancer cell lines, with HaCaT and HUVEC included as non-cancerous controls.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What CBD concentrations and exposure times were tested?",{"text":68,"@type":64},"Cells were treated with CBD at 5, 10, and 20 µM for 24, 48, 72, and 96 hours.",{"name":70,"@type":61,"acceptedAnswer":71},"How was cytotoxicity and cell death characterized?",{"text":72,"@type":64},"Cytotoxicity was assessed using MTT assays, nuclear morphology was evaluated by DAPI staining, and apoptosis/necrosis-related mechanisms were analyzed using flow cytometry markers.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},366896,1790313201,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962090893677,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Article  \nTargeting Human Cancer Cells with Cannabidiol (CBD):  \nApoptotic Cytotoxicity in HeLa, MDA-MB-231, and CaCo-2 Lines  \nCarlos R. Montes-de-Oca-Saucedo 1,†, Jonathan E. Perales-Martínez 2,†, Juan C. Arellano-Barrientos 1,  \nLuis E. Rodríguez-Tovar 2, Alicia M. Nevárez-Garza 2, Aimé J. Garza-Arredondo 2, Odila Saucedo-Cárdenas 1, Gustavo Hernández-Vidal 3, Adolfo Soto-Domínguez 1, * and Uziel Castillo-Velázquez 2, *  \nAcademic Editors: Gabriella Calviello and Simona Serini  \nReceived: 5 July 2025  \nRevised: 3 December 2025  \nAccepted: 10 December 2025  \nPublished: 17 December 2025  \nCitation: Montes-de-Oca-Saucedo, C.R.; Perales-Martínez, J.E.; ArellanoBarrientos, J.C.; Rodríguez-Tovar, L.E.; Nevárez-Garza, A.M.; GarzaArredondo, A.J.; Saucedo-Cárdenas, O.; Hernández-Vidal, G.; SotoDomínguez, A.; Castillo-Velázquez, U. Targeting Human Cancer Cells with Cannabidiol (CBD): Apoptotic Cytotoxicity in HeLa, MDA-MB-231, and CaCo-2 Lines. Int. J. Mol. Sci. 2025, 26, 12136. [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.3390/ijms262412136](10.3390/ijms262412136)  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Departamento de Histología, Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey 64460, Mexico; [carlos.montess@uanl.edu.mx](carlos.montess@uanl.edu.mx) (C.R.M.-d.-O.-S.); [juan.arellanobrr@uanl.edu.mx](juan.arellanobrr@uanl.edu.mx) (J.C.A.-B.); [odila.saucedocr@uanl.edu.mx](odila.saucedocr@uanl.edu.mx) (O.S.-C.)  \n2 Departamento de Inmunología, Facultad de Medicina Veterinaria y Zootecnia, Universidad Autónoma de Nuevo León, Escobedo 66050, Mexico; [jonathan.peralesmrtn@uanl.edu.mx](jonathan.peralesmrtn@uanl.edu.mx) (J.E.P.-M.); [luis.rodrigueztv@uanl.edu.mx](luis.rodrigueztv@uanl.edu.mx) (L.E.R.-T.); [alicia.nevarezgr@uanl.edu.mx](alicia.nevarezgr@uanl.edu.mx) (A.M.N.-G.); [aime.garzaarr@uanl.edu.mx](aime.garzaarr@uanl.edu.mx) (A.J.G.-A.)  \n3 Cuerpo Académico de Patobiología, Facultad de Medicina Veterinaria y Zootecnia, Universidad Autónomade Nuevo León, Escobedo 66050, Mexico; [gustavo.hernandezh@uanl.mx](gustavo.hernandezh@uanl.mx)  \n* Correspondence: [adolfo.sotodmn@uanl.edu.mx](adolfo.sotodmn@uanl.edu.mx) (A.S.-D.); [uziel.castillovl@uanl.edu.mx](uziel.castillovl@uanl.edu.mx) (U.C.-V.); Tel.: +52-81-8329-4195 (A.S.-D.)  \n† These authors contributed equally to this work.  \nAbstract  \nCannabidiol (CBD), a phytocannabinoid derived from Cannabis sativa, has demonstrated therapeutic potential across various diseases, including cancer. This study evaluates the cytotoxic effects of CBD on three human cancer cell lines (HeLa, MDA-MB-231, and CaCo-2) and two non-cancerous cell lines (HaCaT and HUVEC) used as a control. Cells were treated with CBD at concentrations of 5, 10, and 20 µM for 24, 48, 72, and 96 h. Cytotoxicity was assessed using MTT assays, nuclear morphology was evaluated via DAPI staining, and cell death mechanisms were analyzed through flow cytometry with apoptosis/necrosis markers. The LC50 values at 24 h were determined as follows: HeLa (9.4 µM), MDAMB-231 (10.3 µM), and CaCo-2 (4.3 µM) . CBD treatment induced morphological changes characteristic of cell stress and death in cancer cells, observed by optical microscopy after 24, 48, 72, and 96 h of exposure. These findings highlight the potential of CBD as an adjunctive therapeutic agent for cancer treatment versus non-malignant cells.  \nKeywords: cannabidiol (CBD); phytocannabinoids; cytotoxicity; apoptosis; cancer cell lines; LC50  \n1. Introduction  \nCancer is one of the leading causes of mortality worldwide, posing a significant burden on public health and healthcare systems. According to the World Health Organization (WHO), over 19.2 mill","cbCaia9m3JHWobVT","https://ap.wps.com/l/cbCaia9m3JHWobVT","pdf",14345906,21,"English","# Abstract\n# Introduction","[{\"question\":\"Which cell lines were used to evaluate CBD’s cytotoxicity?\",\"answer\":\"HeLa, MDA-MB-231, and CaCo-2 were used as human cancer cell lines, with HaCaT and HUVEC included as non-cancerous controls.\"},{\"question\":\"What CBD concentrations and exposure times were tested?\",\"answer\":\"Cells were treated with CBD at 5, 10, and 20 µM for 24, 48, 72, and 96 hours.\"},{\"question\":\"How was cytotoxicity and cell death characterized?\",\"answer\":\"Cytotoxicity was assessed using MTT assays, nuclear morphology was evaluated by DAPI staining, and apoptosis/necrosis-related mechanisms were analyzed using flow cytometry markers.\"}]","Targeting Human Cancer Cells with Cannabidiol (CBD) - Apoptotic Cytotoxicity in HeLa, MDA-MB-231, and CaCo-2 Lines | PDF",1790168154,53,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3cbf32ad9f9fbbcddc36b052604dd770.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c3a6e743ef8cc4ae940344dfa8142348.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0b42b467546e90ee88ce842f8a3d4504.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/28a3d98a98ee82f15c4cadfb7f199864.webp",980,1385]